Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Safer injection facilities for injection drug users: the debate continues

Evan Wood, Mark W. Tyndall, Thomas Kerr, Patricia M. Spittal, Michael V. O'Shaughnessy and Martin T. Schechter
CMAJ February 19, 2002 166 (4) 422;
Evan Wood
British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Psychology University of Victoria Victoria, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Health Care and Epidemiology University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark W. Tyndall
British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Psychology University of Victoria Victoria, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Health Care and Epidemiology University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Kerr
British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Psychology University of Victoria Victoria, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Health Care and Epidemiology University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia M. Spittal
British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Psychology University of Victoria Victoria, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Health Care and Epidemiology University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael V. O'Shaughnessy
British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Psychology University of Victoria Victoria, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Health Care and Epidemiology University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin T. Schechter
British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Psychology University of Victoria Victoria, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; British Columbia Centre for Excellence in HIV/AIDS St. Paul's Hospital Vancouver, BC; Department of Health Care and Epidemiology University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Metrics
  • Responses
  • PDF
Loading

The answers to the questions raised by Gordon Brock and Vydas Gurekas are quite straightforward. We would hope that safer injecting rooms could operate on a 24-hour basis every day. After all, these are precisely the operating hours of the alleyways and shooting galleries where the public health crisis has emerged. Clients would bring their own drugs and would have access to sterile injecting equipment, which would be disposed of safely on site rather than in parks and schoolyards. Overdoses would be addressed sooner on site by staff, rather than later in ambulances and emergency departments. It is noteworthy that although British Columbia has had an average of 300 overdose deaths per year, there has never been a fatal overdose in any of the 42 safer injecting sites operating across Europe.1

If a safer injecting room only provided sterile injecting equipment and a place to inject where staff could respond to overdoses, it would represent a substantial improvement over the present situation. However, we further propose that referrals to detox, addiction treatment, counselling and primary health care be available for these difficult-to-reach populations. The legal issues have been fully considered by experts in the field and are not insurmountable.2

William Campbell and Nady el-Guebaly rightly point out that the provision of addiction treatment is woefully inadequate in Canada. Access to methadone must be improved, but it will ultimately not reach a significant proportion of opiate users3 or cocaine addicts.4 For these reasons, we concur that novel treatments such as heroin prescription must be explored.5 For those not ready for treatment, programs such as safe injection sites should be implemented to prevent irreversible harms to these people and the health care system while they continue to inject.

Such sites should obviously be located close to where injection drug users presently congregate, such as Vancouver's Downtown Eastside. Brock and Gurekas wonder about the open-mindedness of neighbours, whose reaction may present the largest barrier to implementation of safer injection rooms. Although community concerns will have to be addressed, experience has shown that groups initially opposed to safer injection rooms often later become their strongest supporters, because they find the presence of a safer injecting room more acceptable than the intense open-drug scenes that preceded them.1,6 Why would a neighbour oppose a safer injection room in their backyard, when they currently have unsafe injection scenes in their back alley?

We do indeed live in an era of intense pressures on constrained health care resources. For example, the lifetime direct medical costs associated with each case of HIV infection are in the range of $150 000.7 The costs of hepatitis C infection are also extremely high, and the burden of in-patient care for patients with endocarditis, abscesses, nonfatal overdoses and other drug-related harms is crippling our inner-city hospitals.8 Approximately $300 000 is spent annually on ambulance services to respond to overdoses in Vancouver alone.9

“How can we afford to pay for safe injection sites?” A better question might be, How can we afford not to?

References

  1. 1.↵
    Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Frautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev 2000;19:337-46.
    OpenUrlCrossRef
  2. 2.↵
    Malkin I, Gold J, Elliott R. Safe injection sites: issues, obstacles and obligations. Montreal: Canadian HIV/AIDS Legal Network, 2002.
  3. 3.↵
    Mino A, Page D, Dumont P, Broers B. Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva. Drug Alcohol Depend 1998;50(3):233-9.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Tyndall MW, Spittal PM, Laliberte N, Li K, O'Shaughnessy MV, Schechter MT. Intensive injection cocaine use as a primary risk factor of HIV seroconversion among polydrug users in Vancouver. Can J Infect Dis 2001;12(Suppl B):70B.
    OpenUrl
  5. 5.↵
    Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001;358(9291):1417-23.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Kent H. Australia's safe “shooting gallery” proving popular. CMAJ 2001;165(10):1375.
    OpenUrlFREE Full Text
  7. 7.↵
    Albert T, Williams G, Remis R, Legowski B. Canadian Policy Research Networks. The economic burden of HIV/AIDS in Canada. Ottawa: Renouf Publishing Co. Ltd; 1998.
  8. 8.↵
    Palepu A, Tyndall MW, Leon H, Muller J, O'Shaughnessy MV, Schechter MT, et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ 2001;165(4):415-20.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Kerr, T. Safe injection facilities: a proposal for a Vancouver pilot project. Vancouver: Harm Reduction Action Society; 2000. Available: www.cfdp.ca/safei.pdf (accessed 2002 Jan 18).
PreviousNext
Back to top

In this issue

CMAJ
Vol. 166, Issue 4
19 Feb 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Safer injection facilities for injection drug users: the debate continues
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Safer injection facilities for injection drug users: the debate continues
Evan Wood, Mark W. Tyndall, Thomas Kerr, Patricia M. Spittal, Michael V. O'Shaughnessy, Martin T. Schechter
CMAJ Feb 2002, 166 (4) 422;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Safer injection facilities for injection drug users: the debate continues
Evan Wood, Mark W. Tyndall, Thomas Kerr, Patricia M. Spittal, Michael V. O'Shaughnessy, Martin T. Schechter
CMAJ Feb 2002, 166 (4) 422;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
  • Eliminating racism in research
  • Transitioning to outpatient arthroplasty during COVID-19: time to pivot
Show more Letters

Similar Articles

Collections

  • Topics
    • Addiction medicine

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, CMA Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire